Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 — glucagon-like peptide-1 — receptor ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Millions of Americans have tried GLP-1 medications like Ozempic ... may cause some people to give up on their medications before they reach their weight loss goals or improve their Type 2 diabetes.

Patients who continued Ozempic through total joint arthroplasty had the highest risk for complications. HealthDay News — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 ...

What are GLP-1 agonists? GLP-1 agonists, also known as incretin mimetics, are a class of medication that is primarily used to ...

HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among kidney transplant recipients with diabetes, according to a study ...

Here are 10 takeaways from the study: 1. The study, “Optimal Timing for Cessation of GLP-1 Agonist Before Elective Total Hip and Knee Arthroplasty,” obtained data from the TriNetX Research Network, a ...

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 ... validation after years of being told they simply weren’t trying hard enough. “I was so frustrated before ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

GLP-1 receptor agonists are synthetic drugs that mimic the GLP-1 hormone, which is naturally released in the gut after eating. This hormone helps regulate appetite by creating a feeling of fullness.